Memorandum of Understanding Between the Food and Drug Administration, United States Department of Health and Human Services and the National Alliance for Hispanic Health, 17418-17423 [2010-7673]

Download as PDF 17418 Federal Register / Vol. 75, No. 65 / Tuesday, April 6, 2010 / Notices sroberts on DSKD5P82C1PROD with NOTICES proposed trade name GILENIA (fingolimod hydrochloride) 0.5 milligram (mg) capsules, by Novartis Pharmaceuticals Corp. The proposed indication for this new drug product is treatment of relapsing forms of multiple sclerosis. FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA’s Web site after the meeting. Background material is available at https://www.fda.gov/ AdvisoryCommittees/Calendar/ default.htm. Scroll down to the appropriate advisory committee link. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before May 26, 2010. Oral presentations from the public will be scheduled between approximately 1 p.m. and 2 p.m. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before May 18, 2010. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will VerDate Nov<24>2008 16:37 Apr 05, 2010 Jkt 220001 notify interested persons regarding their request to speak by May 19, 2010. Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Diem-Kieu Ngo at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at https://www.fda.gov/Advisory Committees/AboutAdvisoryCommittees/ ucm111462.htm for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: April 1, 2010. Jill Hartzler Warner, Acting Associate Commissioner for Special Medical Programs. [FR Doc. 2010–7698 Filed 4–5–10; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–N–0004] ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration, U.S. Department of Health and Human Services and the National Alliance for Hispanic Health. The purpose of the MOU is to establish the terms for collaboration to enhance the diversity pool of candidates and to promote shared interests in increasing science and public health internship opportunities for socio-economically disadvantaged students. DATES: The agreement became effective January 21, 2010. FOR FURTHER INFORMATION CONTACT: Mary C. Hitch, Senior Policy Advisor, Office of External Relations, Food and Drug Administration, 5600 Fishers Lane, rm. 15A07, Rockville, MD 20857, 301–827–4406. In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU. SUPPLEMENTARY INFORMATION: Dated: March 29, 2010. Leslie Kux, Acting Assistant Commissioner for Policy. BILLING CODE 4160–01–S Memorandum of Understanding Between the Food and Drug Administration, United States Department of Health and Human Services and the National Alliance for Hispanic Health AGENCY: Food and Drug Administration, HHS. PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\06APN1.SGM 06APN1 VerDate Nov<24>2008 16:37 Apr 05, 2010 Jkt 220001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4725 E:\FR\FM\06APN1.SGM 06APN1 17419 EN06AP10.008</GPH> sroberts on DSKD5P82C1PROD with NOTICES Federal Register / Vol. 75, No. 65 / Tuesday, April 6, 2010 / Notices VerDate Nov<24>2008 Federal Register / Vol. 75, No. 65 / Tuesday, April 6, 2010 / Notices 16:37 Apr 05, 2010 Jkt 220001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4725 E:\FR\FM\06APN1.SGM 06APN1 EN06AP10.009</GPH> sroberts on DSKD5P82C1PROD with NOTICES 17420 VerDate Nov<24>2008 16:37 Apr 05, 2010 Jkt 220001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4725 E:\FR\FM\06APN1.SGM 06APN1 17421 EN06AP10.010</GPH> sroberts on DSKD5P82C1PROD with NOTICES Federal Register / Vol. 75, No. 65 / Tuesday, April 6, 2010 / Notices VerDate Nov<24>2008 Federal Register / Vol. 75, No. 65 / Tuesday, April 6, 2010 / Notices 16:37 Apr 05, 2010 Jkt 220001 PO 00000 Frm 00055 Fmt 4703 Sfmt 9990 E:\FR\FM\06APN1.SGM 06APN1 EN06AP10.011</GPH> sroberts on DSKD5P82C1PROD with NOTICES 17422 Federal Register / Vol. 75, No. 65 / Tuesday, April 6, 2010 / Notices ACTION: [FR Doc. 2010–7673 Filed 4–5–10; 8:45 am] BILLING CODE 4160–01–C DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–N–0004] [FDA 225–10–0007] Memorandum of Understanding Between the Food and Drug Administration, United States Department of Health and Human Services and the Association of Minority Health Profession Schools, Inc. AGENCY: Food and Drug Administration, sroberts on DSKD5P82C1PROD with NOTICES HHS. VerDate Nov<24>2008 16:37 Apr 05, 2010 Jkt 220001 Notice. SUMMARY: The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the FDA, U.S. Department of Health and Human Services and the Association of Minority Health Profession Schools, Inc. The purpose of the MOU is to establish the terms for collaboration to enhance the diversity pool of candidates and to promote shared interests in increasing science and public health internship opportunities for socio-economically disadvantaged students. DATES: The agreement became effective January 20, 2010. FOR FURTHER INFORMATION CONTACT: Mary C. Hitch, Senior Policy Advisor, PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 17423 Office of External Relations, Food and Drug Administration, 5600 Fishers Lane, rm. 15A07, Rockville, MD 20857, 301–827–4406 In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU. SUPPLEMENTARY INFORMATION: Dated: March 29, 2010. Leslie Kux, Acting Assistant Commissioner for Policy. BILLING CODE 4160–01–S E:\FR\FM\06APN1.SGM 06APN1

Agencies

[Federal Register Volume 75, Number 65 (Tuesday, April 6, 2010)]
[Notices]
[Pages 17418-17423]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-7673]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0004]


Memorandum of Understanding Between the Food and Drug 
Administration, United States Department of Health and Human Services 
and the National Alliance for Hispanic Health

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is providing notice of 
a memorandum of understanding (MOU) between the Food and Drug 
Administration, U.S. Department of Health and Human Services and the 
National Alliance for Hispanic Health. The purpose of the MOU is to 
establish the terms for collaboration to enhance the diversity pool of 
candidates and to promote shared interests in increasing science and 
public health internship opportunities for socio-economically 
disadvantaged students.

DATES: The agreement became effective January 21, 2010.

FOR FURTHER INFORMATION CONTACT: Mary C. Hitch, Senior Policy Advisor, 
Office of External Relations, Food and Drug Administration, 5600 
Fishers Lane, rm. 15A07, Rockville, MD 20857, 301-827-4406.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which 
states that all written agreements and MOUs between FDA and others 
shall be published in the Federal Register, the agency is publishing 
notice of this MOU.

    Dated: March 29, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
BILLING CODE 4160-01-S


[[Page 17419]]

[GRAPHIC] [TIFF OMITTED] TN06AP10.008


[[Page 17420]]


[GRAPHIC] [TIFF OMITTED] TN06AP10.009


[[Page 17421]]


[GRAPHIC] [TIFF OMITTED] TN06AP10.010


[[Page 17422]]


[GRAPHIC] [TIFF OMITTED] TN06AP10.011


[[Page 17423]]


[FR Doc. 2010-7673 Filed 4-5-10; 8:45 am]
BILLING CODE 4160-01-C

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.